Evidence map›Paper›PMID 35855803›Full record

ArticleComputational intelligence and neuroscience2022

A Survival Status Classification Model for Osteosarcoma Patients Based on E-CNN-SVM and Multisource Data Fusion.

Qiang Zhang, Peng Peng, Yi Gu

Abstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiang ZhangSchool of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, Jiangsu 214122, China.ORCID https://orcid.org/0000-0002-8429-5998
Peng PengSchool of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, Jiangsu 214122, China.ORCID https://orcid.org/0000-0002-5707-4938
Yi GuSchool of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, Jiangsu 214122, China.ORCID https://orcid.org/0000-0001-7962-9466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional algorithms have the following drawbacks: (1) they only focus on a certain aspect of genetic data or local feature data of osteosarcoma patients, and the extracted feature information is not considered as a whole; (2) they do not equalize the sample data between categories; (3) the generalization ability of the model is weak, and it is difficult to perform the task of classifying the survival status of osteosarcoma patients better. In this context, this paper designs a survival status prediction model for osteosarcoma patients based on E-CNN-SVM and multisource data fusion, taking into full consideration the characteristics of the small number of samples, high dimensionality, and interclass imbalance of osteosarcoma patients' genetic data. The model fuses four gene sequencing data highly correlated with bone tumors using the random forest algorithm in a dimensionality reduction and then equalizes the data using a hybrid sampling method combining the SMOTE algorithm and the TomekLink algorithm; secondly, the CNN model with the incentive module is used to further extract features from the data for more accurate extraction of characteristic information; finally, the data are passed to the SVM model to further improve the stability and classification performance of the model. The model has been demonstrated to be more effective in improving the accuracy of the classification of patients with osteosarcoma.

Indexed as

Bone NeoplasmsOsteosarcomaAlgorithmsHumansSupport Vector Machine

Identifiers

PMID35855803
PMCPMC9288314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.